Evexia Lifecare Limited, a company listed on the Bombay Stock Exchange (BSE), has undergone a significant change in its shareholding structure following a reclassification approved by the BSE. The move has resulted in a decrease in the company's promoter shareholding and a corresponding increase in public shareholding.

Reclassification Details

The BSE has approved the reclassification of three individuals from Evexia Lifecare's promoter group to the public category. The reclassification was carried out under Regulation 31A of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The individuals reclassified are:

1. Santosh Kahar: 12,73,330 shares (0.07% of total shareholding)
2. Mitul Jagdish Thakkar: 9,33,320 shares (0.05% of total shareholding)
3. Patel Bharatbhai Limjibhai: 2,00,000 shares (0.01% of total shareholding)

In total, 24,06,650 shares, representing 0.13% of the company's total shareholding, were reclassified from the promoter group to the public category.

Impact on Shareholding Structure

The reclassification has led to notable changes in Evexia Lifecare's shareholding structure:

As a result of this reclassification:

• The promoter shareholding has decreased from 3.49% to 3.36% of the total shares.
• Public shareholding has increased from 96.51% to 96.64%.

Official Approval and Notification

The reclassification was officially approved by the BSE Limited through an approval letter (no. LIST/COMP/DN/385/2025-26) dated August 18, 2025. Evexia Lifecare Limited promptly informed the BSE about this development on the same day.

Jayeshbhai R. Thakkar, the Chairman & Managing Director of Evexia Lifecare Limited, signed the official intimation to the BSE, confirming the company's compliance with the regulatory requirements for such reclassifications.

This reclassification marks a shift in the company's ownership structure, potentially impacting its governance and public perception. Investors and market watchers may want to take note of this change in Evexia Lifecare's shareholding pattern.

Evexia Lifecare Limited, a prominent player in the pharmaceutical sector, has announced its unaudited financial results for the first quarter, showcasing robust growth across key financial metrics.

Standalone Performance Highlights

The company's standalone performance demonstrated significant improvement:

• Revenue from operations stood at Rs 2,065.80 lakhs, marking a slight increase from Rs 2,041.87 lakhs in the corresponding quarter of the previous year.
• Net profit saw a remarkable surge, rising by 122% to Rs 58.69 lakhs, compared to Rs 26.43 lakhs in the same period last year.
• Basic earnings per share (EPS) remained stable at Rs 0.003 for the quarter.

Consolidated Financial Results

On a consolidated basis, Evexia Lifecare Limited reported:

• Revenue from operations of Rs 2,209.32 lakhs, up from Rs 2,122.79 lakhs in the previous year's quarter.
• Net profit increased substantially to Rs 63.48 lakhs, compared to Rs 24.11 lakhs in the same quarter last year, representing a growth of 163%.
• Consolidated basic earnings per share stood at Rs 0.03 for the quarter.

Key Financial Metrics

Management Commentary

The Board of Directors reviewed and approved these unaudited financial results in their meeting held on August 14.

About Evexia Lifecare Limited

Evexia Lifecare Limited is engaged in the pharmaceutical sector. The company's registered office is located at Village Tundao, Taluka Savli, Vadodara, Gujarat.

Conclusion

Evexia Lifecare's quarterly results demonstrate the company's ability to drive growth and profitability in a competitive market environment. The significant increase in net profit, both on a standalone and consolidated basis, underscores the effectiveness of the company's strategic initiatives and operational excellence.